Dr. Ajay Bakshi is the Managing Director & CEO of Manipal Health Enterprises (Manipal Hospitals) since July 2014. Manipal Hospitals is the corporate healthcare and hospitals entity of the Manipal Education & Medical Group and its healthcare network comprises of 16 hospitals covering 7,000 beds in India and Malaysia. Building on the existing strength and reputation of Manipal Hospitals for clinical excellence, Dr Bakshi is leading a digital transformation of its core business model, as well as leading an organizational transformation to make the entire hospital network more empathic and friendly towards patients and their families.
Prior to Manipal, in 2011 – Dr. Bakshi worked at Max Healthcare as their MD & CEO where he led a succesful launch of 4 new hospitals as well as a comprehensive turn-around of the overall network. Dr. Bakshi trained as a neurosurgeon: he has an MBBS and M.Ch. (Neurosurgery) degrees from All India Institute of Medical Sciences (AIIMS), New Delhi. After finishing his Chief Residency, he has worked as a Consultant Neurosurgeon at Vidya Sagar Institute of Mental Health & Neurosciences (VIMHANS), New Delhi. During this period he started a successful endoscopic neurosurgery practice, in addition to performing more than 600 major brain and spinal surgeries for complex neurosurgical conditions.
In 2002, he transitioned to a research role at Dept. of Neurobiology, Drexel University College of Medicine, Philadelphia, where he built a research program around minimally invasive stem cell transplantation for spinal cord injuries. Based on an R21 research grant that he received from National Institute of Health, Dr. Bakshi developed and demonstrated the safety and efficacy of Autologous Stem Cell transplantation via lumbar puncture technique in animal models - a procedure that is becoming main stream for Human Stem Cell transplantation now. At the same time, he also completed the 2 year Wharton Management Program from The Wharton School.
In 2005, Dr. Bakshi joined McKinsey and Company, New Jersey and served large US corporations in Medical devices, Hospitals, Pharmaceuticals and Health Insurance sectors around questions related to their Strategy, Organizations and Operations. In 2008, he moved to their Dubai Office and got an opportunity to serve Prime Ministers and Health Ministers of the Middle East and African countries on questions related to the design and effectiveness of their countries' Health Systems. He left McKInsey in 2011 as an Associate Principal to join Max Healthcare as their CEO.